The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies DOI Creative Commons

Puguang Yu,

Chunming Zhu,

Xiangyun You

и другие.

Cell Death and Disease, Год журнала: 2024, Номер 15(6)

Опубликована: Июнь 19, 2024

Abstract With the high incidence of urogenital tumors worldwide, urinary system are among top 10 most common in men, with prostate cancer ranking first and bladder fourth. Patients resistant often have poor prognosis. In recent years, researchers discovered numerous specific antigens, which has led to development several new anti-cancer drugs. Using protein analysis techniques, developed immune checkpoint inhibitors (ICIs) antibody-conjugated drugs (ADCs) for treatment advanced tumors. However, tumor resistance leads failure monotherapy. Therefore, clinical trials combination ICIs ADCs been carried out centers around world. This article reviewed phase 2 3 studies ICIs, ADCs, their highlight safe effective methods selecting individualized therapeutic strategies patients. activate system, whereas link monoclonal antibodies toxins, can achieve a synergistic effect when two combined. provides multiple advantages

Язык: Английский

The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review DOI
Asif Ahmad Bhat, Riya Thapa, Obaid Afzal

и другие.

International Journal of Biological Macromolecules, Год журнала: 2023, Номер 242, С. 124832 - 124832

Опубликована: Май 15, 2023

Язык: Английский

Процитировано

102

Immunoadjuvant-Functionalized Metal-Organic Frameworks:Synthesis and Applications in Tumor Immune Modulation DOI
Chen Zhao, Weihua Song,

Jianing Wang

и другие.

Chemical Communications, Год журнала: 2024, Номер unknown

Опубликована: Дек. 23, 2024

This review explores the synthesis, drug loading, and surface modifications of metal–organic frameworks (MOFs), highlighting their role in improving cancer immunotherapy paving way for safer more effective treatments.

Язык: Английский

Процитировано

53

From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression DOI
Riya Thapa, Obaid Afzal, Muhammad Afzal

и другие.

Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 154959 - 154959

Опубликована: Ноя. 19, 2023

Язык: Английский

Процитировано

50

Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer DOI
Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa

и другие.

Cytokine, Год журнала: 2023, Номер 171, С. 156376 - 156376

Опубликована: Сен. 23, 2023

Язык: Английский

Процитировано

49

A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer’s Disease Risk in Older Men with Prostate Cancer DOI Open Access
Manisha Singh, Vinayak Agarwal, Pranav Pancham

и другие.

Degenerative Neurological and Neuromuscular Disease, Год журнала: 2024, Номер Volume 14, С. 33 - 46

Опубликована: Май 1, 2024

Abstract: Prostate cancer (PCa) is one of the most prevalent malignancies affecting males worldwide. Despite reductions in mortality rates due to advances early identification and treatment methods, PCa remains a major health concern. Recent research has shed light on possible link between Alzheimer's disease (AD), which significant neurological ailment that affects older all over world. Androgen deprivation therapy (ADT), cornerstone therapeutic method used conjunction with radiation palliative care advanced metastatic cases, critical for management. Evidence reveals relationship ADT cognitive impairment. Hormonal manipulation may cause long-term problems through processes such as amyloid beta (Aβ) aggregation neurofibrillary tangles (NFTs). Fluctuations basal androgen levels can upset delicate balance genes are sensitive levels, contributing This detailed review dives into various aspects aetiology its decline. It investigates discovery particular biomarkers, well microRNAs (miRNAs), play important roles pathogenic progression. The attempts identify potential biomarkers associated ADT-induced cerebral changes, including Aβ oligomer buildup, NFT formation, tauopathy, contribute early-onset dementia Besides it further aims provide insights innovative diagnostic avenues alleviating ADT-related sequelae by unravelling these complicated pathways molecular mechanisms. Keywords: cancer, dementia, defects, androgen, testosterone

Язык: Английский

Процитировано

33

The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway DOI Open Access
Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani

и другие.

Cancers, Год журнала: 2024, Номер 16(8), С. 1554 - 1554

Опубликована: Апрель 18, 2024

Cancer is a life-threatening disease and one of the leading causes death worldwide. Despite significant advancements in therapeutic options, most available anti-cancer agents have limited efficacy. In this context, natural compounds with diverse chemical structures been investigated for their multimodal properties. Curcumin polyphenol isolated from rhizomes Curcuma longa has widely studied its anti-inflammatory, anti-oxidant, effects. acts on regulation different aspects cancer development, including initiation, metastasis, angiogenesis, progression. The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) pathway key target therapy, since it implicated proliferation, cell survival. found to inhibit PI3K/Akt tumor cells, primarily via mediators, growth factors, protein kinases, cytokines. This review presents potential curcumin malignancies, such as glioblastoma, prostate breast cancer, head neck cancers, through targeting signaling pathway.

Язык: Английский

Процитировано

30

Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives DOI
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazeer Hasan

и другие.

European Polymer Journal, Год журнала: 2024, Номер 206, С. 112800 - 112800

Опубликована: Янв. 26, 2024

Язык: Английский

Процитировано

29

Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021 DOI Creative Commons
Zeng‐Hong Wu,

Fangnan Xia,

Rong Lin

и другие.

Journal of Hematology & Oncology, Год журнала: 2024, Номер 17(1)

Опубликована: Ноя. 29, 2024

Cancer is the second most common cause of death globally. Therefore, it imperative to investigate cancer incidence, mortality rates, and disability-adjusted life years (DALYs) enhance preventive measures healthcare resource allocation. This study aimed assess burden associated risk factors in 204 countries territories between 1980 2021. We selected data on incidence rates from global disease (GBD) tool for 1990 2021 estimated age-standardized (ASIR) deaths (ASDR) 34 types categorized as level 3 causes based GBD hierarchy. In 2021, accounted 14.57% (95% uncertainty interval: 13.65–15.28) total 8.8% (7.99–9.67) DALYs both sexes ASIR ASDR were 790.33 (694.43–893.01) 116.49 (107.28–124.69), respectively. Additionally, females exhibited higher than males (923.44 versus 673.09), while (145.69 93.60). indicates that policymakers should focus importance gender equality healthcare. Non-melanoma skin highest (74.10) sexes, digestive cancers 39.29% all cancer-related deaths, Asia heaviest burden. females, breast (46.40) (14.55). males, tracheal, bronchial, lung (37.85) (34.32), highlighting urgent need targeted tobacco control measures. Different various exhibit unique characteristics. formulate specific prevention strategies reflect their country. Tobacco was primary 2 factor males. It 29.32% (25.32–33.14) DALYs. Dietary risks, alcohol consumption, air pollution 5.89% (2.01–10.73), 5.48% (4.83–6.11), 4.30% (2.77–5.95) male DALYs, prioritize smoking regulation other carcinogenic risks. a significant public health concern Understanding etiologies different essential developing effective interventions.

Язык: Английский

Процитировано

25

CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression DOI Creative Commons

Yanan Gu,

Shiqi Wu,

Junjie Fan

и другие.

Cell Death and Disease, Год журнала: 2024, Номер 15(1)

Опубликована: Янв. 22, 2024

Abstract Prostate cancer (PCa) is one of the most common malignancy in men. However, molecular mechanism its pathogenesis has not yet been elucidated. In this study, we demonstrated that CYLD, a novel deubiquitinating enzyme, impeded PCa development and progression via tumor suppression. First, found CYLD was downregulated tissues, expression inversely correlated with pathological grade clinical stage. Moreover, discovered inhibited cell proliferation enhanced sensitivity to ferroptosis vitro vivo, respectively. Mechanistically, suppressed ubiquitination YAP protein, then promoted ACSL4 TFRC mRNA transcription. Then, could enhance xenografts vivo. Furthermore, for first time there positive correlation between or human specimens. The results study suggested acted as suppressor gene through Hippo/YAP signaling.

Язык: Английский

Процитировано

21

Lanthanide MOF-based luminescent sensor arrays for the detection of castration-resistant prostate cancer curing drugs and biomarkers DOI Creative Commons
Xinrui Wang,

Karuppasamy Gopalsamy,

Gilles Clavier

и другие.

Chemical Science, Год журнала: 2024, Номер 15(17), С. 6488 - 6499

Опубликована: Янв. 1, 2024

In recent years, castration-resistant prostate cancer (CRPC) has profoundly impacted the lives of many men, and early diagnosis medication illness is crucial. Therefore, a highly efficient detection method for CRPC biomarkers curing drugs required. However, complex diverse structures pose significant challenges their differentiation. Lanthanide metal-organic frameworks (Ln-MOFs) show great potential sensing applications due to intense characteristic luminescence. this work, series new bimetallic Ln-MOFs (Eu

Язык: Английский

Процитировано

21